NIH-funded research R01 grant

Auditory brain changes after inner ear gene therapy in adults who are deaf

Official title: Auditory encoding, perception, and plasticity in the deaf adult brain following inner ear gene therapy

Funded at Massachusetts Eye and Ear Infirmary · NIH-11429454 · Data updated 2026-11-12

This grant tests how an adult with congenital deafness begins to hear after a gene therapy in the inner ear, and how the brain adapts to these new sounds.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMassachusetts Eye and Ear Infirmary
NIH-funded
Lab location1 site (Boston, United States)
Project startJuly 10, 2026
Project endMay 31, 2031
Funding year2026
Award (this year)$701,848
NIH project number1R01DC023999-01
Project IDNIH-11429454 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with congenital hearing loss who could potentially benefit from inner-ear gene therapies and subsequent brain-level processing changes.

Less likely to help

Patients without access to gene therapy or with different forms of hearing loss may not experience the same brain changes or benefits.

What this research studies

The project studies how the ear and brain respond when a gene therapy is used to restore hearing in adult mice that were born deaf. Researchers deliver otoferlin gene therapy to the inner ear and monitor hearing ability, brain responses, and behavior over weeks. They combine brain recordings and behavioral tests to see how cortical sound processing emerges despite early deafness and how this informs human therapies. This work could reveal notes on timing, plasticity, and limits of recovering hearing with gene-based approaches.

Why it matters

Potential benefit: If successful, the research could guide future gene therapies to restore hearing in humans and improve understanding of how the adult brain can adapt to new auditory input.

How similar studies have gone: Preclinical studies in deaf mice show rapid cortical responses after gene therapy, suggesting potential for translational progress in humans.

Where this research is happening

  • Massachusetts Eye and Ear Infirmary
    Boston, United States
    Active

Researchers

  • Principal investigator: Clayton, Kameron — Massachusetts Eye and Ear Infirmary
  • Study coordinator: Clayton, Kameron

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.